Michpal: How Much Of The Cash Pile Is Really Free After Puts, Earnouts, And Tzviran

The main article made a sharp point: Michpal’s post-IPO cash pile looks large, but it is not truly sitting free next to common shareholders. This follow-up isolates only that issue. Not whether the core engine is growing, and not whether the acquisition strategy makes sense in principle, but how much of the year-end cash is really available once you layer in the puts, the earnouts, the bank debt, the dividend approved after the balance-sheet date, and the next trigger called Tzviran.

Finding one: NIS 286.1 million of cash and cash equivalents is a consolidated number. At the parent-company level, the layer from which dividends and M&A decisions are actually made, cash and cash equivalents stand at NIS 248.6 million. Even before any liability is considered, about NIS 37.5 million already sits outside the listed parent’s direct cash box.

Finding two: the balance sheet already includes NIS 148.2 million of put liabilities to minority holders and NIS 26.0 million of contingent consideration liabilities. That does not mean every shekel leaves tomorrow morning. It does mean the cash is already burdened by economic claims created by Michpal’s own acquisition model.

Finding three: bank debt at year-end 2025 is only NIS 50.0 million, and the company is in compliance with all covenants. So this is not a balance-sheet distress read. It is something else: comfortable covenants can coexist with thin shareholder-accessible flexibility, because banks measure financial debt and EBITDA, not the full economic cost of puts and earnouts.

Finding four: on January 14, 2026, the Israeli Competition Authority approved the Tzviran acquisition. As of March 22, 2026, the deal was still not completed and therefore was not yet recognized on the balance sheet. But once a major closing condition has already been cleared, the question of how much cash is really free moves from theory to near-term capital allocation.

Where The Cash Actually Stops Being Free

The easy way to read Michpal is to look at NIS 286.1 million of cash and cash equivalents and conclude that the company exited the IPO with a war chest that can fund almost anything. That is too flat a reading. In the parent-only financial statements, cash and cash equivalents stand at NIS 248.6 million. That is already a different number, and it is the one that matters when the question is what is genuinely accessible to shareholders or available for the next acquisition.

From there, the screening becomes more real. The balance sheet already carries NIS 50.0 million of bank debt, NIS 26.0 million of contingent consideration liabilities, and NIS 148.2 million of put liabilities to holders of non-controlling interests. Then comes the post-balance-sheet event: on March 22, 2026, the board approved a dividend of NIS 0.31 per share, about NIS 5.43 million in total, with payment set for April 14, 2026.

Put differently, the cash pile that looks generous at the start of the sentence shrinks quickly once it is framed as all-in cash flexibility. On the parent-company basis, after bank debt, put liabilities, contingent consideration, and the dividend approved after year-end, the residual balance falls to about NIS 18.9 million. Even if one prefers a consolidated framing rather than a parent-only framing, the picture is still much tighter than the raw cash number implies.

That chart is not claiming that every one of those liabilities comes due on the same day. It is separating two different questions. The first question is whether there is cash in the group. There is. The second is whether that cash is genuinely free for new shareholder decisions. That second picture is much less generous.

Who Already Has A Claim On That Cash

The largest component in the overhang is the put layer to minority holders. At year-end 2025, the liability for those put options stood at NIS 148.249 million, up from NIS 113.456 million a year earlier. The meaning is not that Michpal received an immediate NIS 148 million cash call. The meaning is that part of the economic price of earlier acquisitions still has not been paid in full and has instead been deferred through call and put structures.

The heaviest single item is V-IT at NIS 70.516 million. Then come Meida Machshevim at NIS 36.713 million, Paperless at NIS 16.061 million, Amlogic at NIS 8.866 million, Mishmarot at NIS 8.448 million, Heshav at NIS 6.0 million, and Linkatch at NIS 1.645 million. This is not a side note. It is a little more than half of the group’s year-end cash balance.

The earnout layer is not theoretical either. Year-end 2025 closed with NIS 26.020 million of contingent consideration liabilities, after the company had already paid NIS 10.555 million during the year on acquisitions from prior periods. That matters because it shows this layer is not merely sitting in the balance sheet. It is also consuming real cash. At the same time, the liability did not disappear, because new acquisitions were added during the year and the company also recorded NIS 5.211 million of remeasurement expense.

The composition of that layer matters as well. Paperless alone accounts for NIS 22.954 million out of the NIS 26.0 million total. Mishmarot adds another NIS 2.217 million and Linkatch another NIS 0.85 million. In other words, most of the remaining contingent consideration is concentrated in the newer deals, exactly where the group still needs to prove integration and the conversion of growth into accounting and cash.

That table sharpens the key point. Some of these payments are still years away, but their economics already sit inside today’s cash story. That is exactly why NIS 148.2 million of puts and NIS 26.0 million of contingent consideration are not a soft “maybe.” They are an existing claim layer whose value will keep moving with the acquired companies’ performance, the discounting assumptions, and the exercise timing.

It is also important not to read the number like a fixed invoice. In the financial-instruments note, Michpal measures both layers at Level 3 fair value using discounted cash flow and Monte Carlo models. The discount rates used for contingent consideration range from 4.9% to 5.5%, and those used for the put liabilities range from 5.0% to 5.7%. So NIS 148.2 million is not a simple coupon-bearing debt number. It is the current estimate of a future economic price. But a current estimate is still a claim on cash, not a cash cushion.

Why Covenants Look Better Than The Shareholder Cash Picture

Anyone reading only the debt note could end up too relaxed. At year-end 2025, Michpal’s bank debt stands at NIS 50 million, split between NIS 30 million short-term and NIS 20 million long-term. Under the bank agreements, the company undertook to keep net financial debt to EBITDA below 5, and below 3 for distributions or management fees to the controlling shareholder. At year-end it complies with all those undertakings, and the debt-agreement table even states that the company has net excess cash and therefore a debt-coverage ratio below zero.

That is true, but it answers a different question. Banks measure net financial debt, not acquisition overhang. The working-capital presentation in the business chapter explicitly excludes the liabilities for business combinations, contingent consideration, and put liabilities. So all three of the following statements can be true at the same time:

1. Michpal is not under covenant pressure.
2. Michpal holds a large amount of cash.
3. A large part of that cash is not truly free for common shareholders.

That tension is not an accounting contradiction. It reflects the fact that banks and equity holders are asking different questions. Banks ask whether bank debt is supported by cash flow and EBITDA. Shareholders need to ask how much cash remains after the acquisition stack starts asking for its share. Those are very different tests.

In that sense, comfortable covenants are not proof that the cash is free. They are the reason the debate has moved away from the banks and toward capital allocation. Michpal replaced shareholder loans with equity, used about NIS 57.75 million of IPO proceeds to repay bank debt, and ended the year with a relatively light bank-debt load. But it did not remove the economic price tag attached to the acquisition strategy. It only moved the pressure from direct financing dependence to the question of how quickly that liability layer will convert into real cash outflow.

Tzviran Is The Next Trigger

Up to this point, the story is mostly about liabilities already recognized in the balance sheet. Tzviran is the next layer, which is why it matters so much. On November 13, 2025, Michpal signed an agreement to acquire 60% of Tzviran Group. On January 14, 2026, the company received the Competition Authority approval. As of the date the financial statements were approved, March 22, 2026, not all closing conditions had yet been satisfied, and Michpal therefore had not recognized Tzviran’s assets and liabilities in the financial statements.

But the fact that the deal is still off-balance-sheet does not make it irrelevant to the cash question. Under the agreement, Michpal is supposed to pay NIS 48.0 million in cash at completion. Within that structure, NIS 9.0 million out of that amount, as well as an additional payment of up to NIS 8.4 million, depend on Tzviran’s operating results in 2026 to 2028. So before one even gets to the later put window in 2028 to 2032, there is already a real cash trigger that has moved materially closer from a regulatory perspective.

The interaction between the post-balance-sheet dividend and Tzviran is the core of the read. On a consolidated basis, after bank debt, put liabilities, contingent consideration, and the dividend approved after year-end, about NIS 56.4 million remain. That is roughly the same size as the disclosed Tzviran cash envelope if one takes the NIS 48 million cash leg and the additional up-to-NIS 8.4 million payment together. On the parent-company basis, as the opening chart showed, the residual buffer is already down to about NIS 18.9 million even before Tzviran.

This is not an argument that Michpal must raise capital tomorrow morning. It is a more precise argument: Michpal’s cash is no longer an open option. It is already tagged by past acquisitions, and it may be tagged again very quickly by a further acquisition whose regulatory path has already advanced.

Conclusion

Michpal did not finish 2025 as a company without cash. It finished 2025 as a company whose cash is already sitting inside a queue of claims. That is a very different picture. The IPO did replace shareholder loans with equity, allow bank-debt repayment, and leave the company with an impressive headline cash balance. But that balance now meets three claim layers: puts already recognized in the balance sheet, contingent consideration already leaking into cash, and Tzviran, which still sits outside the balance sheet but is much closer to cash deployment than the phrase “not yet completed” may suggest.

The reasonable counter-thesis is that this reading is too conservative. One can argue that the put layer is spread over years, that part of the contingent consideration may yet settle lower, and that the company still holds net excess cash versus the banks. All of that is true. But that is exactly the point: banking comfort is not the same as shareholder comfort. What matters for shareholders is not whether Michpal passes the covenant test, but how much cash remains once the acquisition stack starts asking for its share.

That is why 2026 looks less like a “we have plenty of cash” year and more like a capital-allocation proof year. If Michpal closes Tzviran without reopening the leverage question, and if the put and earnout layers start declining in cash faster than they are rebuilt through new deals, the read improves. If not, the cash number will keep looking stronger in the headline than it does in the hands of shareholders.